Modest association between the discharge modified rankin scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis

David Asuzu, Karin Nyström, Hardik Amin, Joseph Schindler, Charles Wira, David Greer, Nai-Fang Chi, Janet Halliday, Kevin N. Sheth

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background Thirty- and 90-day modified Rankin Scale (mRS) scores are used to monitor adverse outcome or symptomatic intracerebral hemorrhage (sICH) in ischemic stroke patients after intravenous (IV) thrombolytic therapy. Discharge mRS scores are more readily available and could serve as a proxy for 30- or 90-day mRS data. Our goal was to evaluate agreement between the discharge mRS score and sICH. Additionally, we tested for correlations between the discharge mRS score and 8 clinical scores developed to predict sICH or adverse outcomes based on 90-day mRS data. Methods Clinical data were analyzed from 210 patients receiving IV thrombolysis from January 2009 till December 2013 at the Yale New Haven Hospital. Agreement between sICH and the discharge mRS score was assessed using linear kappa. Eight clinical scores were calculated for each patient and compared with the discharge mRS score by univariate logistic regression. Goodness of fit was tested by receiver operating characteristic (ROC) analysis and by Hosmer-Lemeshow statistics. Results We found only modest agreement between sICH and unfavorable discharge mRS scores (mRS ≥5), with kappa.22, P =.0001. All 8 clinical scores tested showed good agreement with discharge mRS score of 5 or more (ROC area >.7). Conclusions The discharge mRS score shows only modest agreement with sICH and therefore cannot be recommended as a proxy for 30- or 90-day mRS data. However, the discharge mRS score correlates strongly with clinical scores predicting long-term adverse outcome; therefore, assessment of discharge mRS scores may be of some clinical benefit.

Original languageEnglish
Pages (from-to)548-553
Number of pages6
JournalJournal of Stroke and Cerebrovascular Diseases
Volume24
Issue number3
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Cerebral Hemorrhage
Proxy
ROC Curve
Thrombolytic Therapy
Logistic Models
Stroke

Keywords

  • alteplase
  • hemorrhagic transformation
  • Ischemic stroke
  • IV thrombolysis
  • modified Rankin scale
  • symptomatic intracerebral hemorrhage

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Rehabilitation
  • Cardiology and Cardiovascular Medicine

Cite this

Modest association between the discharge modified rankin scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis. / Asuzu, David; Nyström, Karin; Amin, Hardik; Schindler, Joseph; Wira, Charles; Greer, David; Chi, Nai-Fang; Halliday, Janet; Sheth, Kevin N.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 24, No. 3, 01.03.2015, p. 548-553.

Research output: Contribution to journalArticle

Asuzu, David ; Nyström, Karin ; Amin, Hardik ; Schindler, Joseph ; Wira, Charles ; Greer, David ; Chi, Nai-Fang ; Halliday, Janet ; Sheth, Kevin N. / Modest association between the discharge modified rankin scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis. In: Journal of Stroke and Cerebrovascular Diseases. 2015 ; Vol. 24, No. 3. pp. 548-553.
@article{11bf5d5237394c299c5c7b4d46db0de7,
title = "Modest association between the discharge modified rankin scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis",
abstract = "Background Thirty- and 90-day modified Rankin Scale (mRS) scores are used to monitor adverse outcome or symptomatic intracerebral hemorrhage (sICH) in ischemic stroke patients after intravenous (IV) thrombolytic therapy. Discharge mRS scores are more readily available and could serve as a proxy for 30- or 90-day mRS data. Our goal was to evaluate agreement between the discharge mRS score and sICH. Additionally, we tested for correlations between the discharge mRS score and 8 clinical scores developed to predict sICH or adverse outcomes based on 90-day mRS data. Methods Clinical data were analyzed from 210 patients receiving IV thrombolysis from January 2009 till December 2013 at the Yale New Haven Hospital. Agreement between sICH and the discharge mRS score was assessed using linear kappa. Eight clinical scores were calculated for each patient and compared with the discharge mRS score by univariate logistic regression. Goodness of fit was tested by receiver operating characteristic (ROC) analysis and by Hosmer-Lemeshow statistics. Results We found only modest agreement between sICH and unfavorable discharge mRS scores (mRS ≥5), with kappa.22, P =.0001. All 8 clinical scores tested showed good agreement with discharge mRS score of 5 or more (ROC area >.7). Conclusions The discharge mRS score shows only modest agreement with sICH and therefore cannot be recommended as a proxy for 30- or 90-day mRS data. However, the discharge mRS score correlates strongly with clinical scores predicting long-term adverse outcome; therefore, assessment of discharge mRS scores may be of some clinical benefit.",
keywords = "alteplase, hemorrhagic transformation, Ischemic stroke, IV thrombolysis, modified Rankin scale, symptomatic intracerebral hemorrhage",
author = "David Asuzu and Karin Nystr{\"o}m and Hardik Amin and Joseph Schindler and Charles Wira and David Greer and Nai-Fang Chi and Janet Halliday and Sheth, {Kevin N.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2014.09.034",
language = "English",
volume = "24",
pages = "548--553",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Modest association between the discharge modified rankin scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis

AU - Asuzu, David

AU - Nyström, Karin

AU - Amin, Hardik

AU - Schindler, Joseph

AU - Wira, Charles

AU - Greer, David

AU - Chi, Nai-Fang

AU - Halliday, Janet

AU - Sheth, Kevin N.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background Thirty- and 90-day modified Rankin Scale (mRS) scores are used to monitor adverse outcome or symptomatic intracerebral hemorrhage (sICH) in ischemic stroke patients after intravenous (IV) thrombolytic therapy. Discharge mRS scores are more readily available and could serve as a proxy for 30- or 90-day mRS data. Our goal was to evaluate agreement between the discharge mRS score and sICH. Additionally, we tested for correlations between the discharge mRS score and 8 clinical scores developed to predict sICH or adverse outcomes based on 90-day mRS data. Methods Clinical data were analyzed from 210 patients receiving IV thrombolysis from January 2009 till December 2013 at the Yale New Haven Hospital. Agreement between sICH and the discharge mRS score was assessed using linear kappa. Eight clinical scores were calculated for each patient and compared with the discharge mRS score by univariate logistic regression. Goodness of fit was tested by receiver operating characteristic (ROC) analysis and by Hosmer-Lemeshow statistics. Results We found only modest agreement between sICH and unfavorable discharge mRS scores (mRS ≥5), with kappa.22, P =.0001. All 8 clinical scores tested showed good agreement with discharge mRS score of 5 or more (ROC area >.7). Conclusions The discharge mRS score shows only modest agreement with sICH and therefore cannot be recommended as a proxy for 30- or 90-day mRS data. However, the discharge mRS score correlates strongly with clinical scores predicting long-term adverse outcome; therefore, assessment of discharge mRS scores may be of some clinical benefit.

AB - Background Thirty- and 90-day modified Rankin Scale (mRS) scores are used to monitor adverse outcome or symptomatic intracerebral hemorrhage (sICH) in ischemic stroke patients after intravenous (IV) thrombolytic therapy. Discharge mRS scores are more readily available and could serve as a proxy for 30- or 90-day mRS data. Our goal was to evaluate agreement between the discharge mRS score and sICH. Additionally, we tested for correlations between the discharge mRS score and 8 clinical scores developed to predict sICH or adverse outcomes based on 90-day mRS data. Methods Clinical data were analyzed from 210 patients receiving IV thrombolysis from January 2009 till December 2013 at the Yale New Haven Hospital. Agreement between sICH and the discharge mRS score was assessed using linear kappa. Eight clinical scores were calculated for each patient and compared with the discharge mRS score by univariate logistic regression. Goodness of fit was tested by receiver operating characteristic (ROC) analysis and by Hosmer-Lemeshow statistics. Results We found only modest agreement between sICH and unfavorable discharge mRS scores (mRS ≥5), with kappa.22, P =.0001. All 8 clinical scores tested showed good agreement with discharge mRS score of 5 or more (ROC area >.7). Conclusions The discharge mRS score shows only modest agreement with sICH and therefore cannot be recommended as a proxy for 30- or 90-day mRS data. However, the discharge mRS score correlates strongly with clinical scores predicting long-term adverse outcome; therefore, assessment of discharge mRS scores may be of some clinical benefit.

KW - alteplase

KW - hemorrhagic transformation

KW - Ischemic stroke

KW - IV thrombolysis

KW - modified Rankin scale

KW - symptomatic intracerebral hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=84924540025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924540025&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2014.09.034

DO - 10.1016/j.jstrokecerebrovasdis.2014.09.034

M3 - Article

VL - 24

SP - 548

EP - 553

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 3

ER -